Discussing Decision-Making Capacity Assessment is vital because as our population ages, the demand for physicians to be proficient in this area is increasing. Family physicians, being at the forefront of patient care, play a pivotal role not only in diagnosing and managing dementia but also in evaluating decision-making capacity.

Learning objectives:  

1.      Discuss the circumstances in which a capacity assessment is necessary. 

2.      Identify the appropriate tools and methods to conduct a standardized capacity assessment. 

In episode 575, James and Mike invite Jamie Falk back to the podcast to help us sift through all the evidence for using oral contraceptives and spironolactone to treat acne. We find that they actually do work. We go over all the numbers for the benefits and harms. Have a listen.

Show notes Tools for Practice Facing the Evidence in Acne, Part I: Oral contraceptives and spironolactone in females

In episode 574, James and Mike invite Jennifer Young back to the podcast to help us yet again look at the evidence for cranberries and the prevention of UTI’s. Unfortunately, there is a problem with the evidence as there is a high risk-of-bias from potential publication bias, small studies, and unblinding. However, if we look past some of these biases, cranberry products might be worth a try. But have a listen and see what the evidence says.

Show notes 1) Tools for Practice Any berry good solutions to preventing UTIs: Cranberries? 2) MAKING EVIDENCE MATTER for EVERYONE CONFERENCE Vancouver May 24/25, 2024

In this episode, Mike, Jess and Jennifer discuss the case of Myles Tension who was originally presented in Episode #1. Myles is back for a follow up appointment to discuss the management of his blood pressure. 

If you haven't already listened to Episode #1, check it out: https://open.spotify.com/episode/4uO4L7AgmVYDiBLJYFlXeB?si=e8c234c3a22a48db).

To claim your Mainpro+ credit for listening to this podcast, click here: https://cfpclearn.ca/podcast/in-the-clinic-episode-17-hypertension-part-ii/. 

In this episode, Mike and Jess are joined by family physician Jennifer Young. The team discusses Hans Goteborg, a 58 year old patient whose appointment today focusses on cancer screening.

To claim your Mainpro+ credit for listening to this podcast, click here: https://cfpclearn.ca/podcast/in-the-clinic-episode-16-cancer-screening/. 

In this episode, Mike, Jess and Émélie discuss patient, Liz Hall, who presents with diarrhea. The team discusses potential causes for the diarrhea, including a workup for C. difficile diarrhea. 

To claim your Mainpro+ credit for listening to this podcast, click here: https://cfpclearn.ca/podcast/in-the-clinic-episode-15-clostridium-difficile/. 

In this episode, Mike, Jess and Émélie Braschi, discuss Ana Flax who presents with seasonal allergies. Ana also has a history of penicilin allergy and the team discusses the likelihood that she has a true penicillin allergy.

To claim your Mainpro+ credit for listening to this podcast, click here: https://cfpclearn.ca/podcast/in-the-clinic-episode-14-allergies/ 

This episode will review the ways that 2SLGBTQ+ patients can experience homelessness differently than the general population, and how to best support them in your practice.

Learning objectives:

1. Understanding the factors affecting 2SLGBTQ individuals experiencing homelessness on a population level
2. Recognizing the importance of screening for poverty and housing insecurity, especially in the 2SLGBTQ population
3. Developing strategies to support and stabilize 2SLGBTQ patients experiencing homelessness.

In episode 573, James and Mike invite Jamie Falk back to the podcast to help us simplify all the evidence around using antipsychotics for difficult to treat depression. They do seem to “work”, but you really need to know the numbers around what “work” means. At the end of the podcast, you will!

Show notes 1) Tools for Practice Overcoming Resistance: Antipsychotics for difficult to treat depression

2) MAKING EVIDENCE MATTER for EVERYONE CONFERENCE Vancouver May 24/25, 2024

In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed decisions.

Show Notes 1) Tools for Practice Preventing RSV Infections in Infants

2) MAKING EVIDENCE MATTER for EVERYONE CONFERENCE Vancouver May 24/25, 2024 https://hectalks.com